Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic impact of RAS-pathway mutations in patients with myelofibrosis

18 Oct 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Eosinophilic Disorders and Syndromes
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 31628430
DOI: 10.1038/s41375-019-0603-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic impact of RAS-pathway mutations in patients with myelofibrosisPMID 31628430Read ↗

[Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis].Semantic proximity Read ↗

[Molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes].Semantic proximity Read ↗

Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients.Semantic proximity Read ↗

Driver mutations' effect in secondary myelofibrosis: an international multicenter study based on 781 patients.Semantic proximity Read ↗

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patientsSemantic proximity Read ↗

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions.Semantic proximity Read ↗

Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.Semantic proximity Read ↗

The role of ras gene mutations in myeloproliferative disorders.Semantic proximity Read ↗

Germline RBBP6 mutations in familial myeloproliferative neoplasmsSemantic proximity Read ↗

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapySemantic proximity Read ↗

NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromesSemantic proximity Read ↗

RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.